EUVIMEDEUVIMED entdecken
Fallbericht

Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma

Ichiro Sakanoue iD, Masatsugu Hamaji iD, Daisuke Nakajima, Hiroshi Date

The Thoracic and Cardiovascular Surgeon · 01.01.2025 · 73 (01) · 086-089

DOI: 10.1055/a-2411-7055 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2025. Verfasst von Ichiro Sakanoue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Kidney Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of oligometastatic renal cell carcinoma with pulmonary metastases is controversial and occasionally requires multimodality management, including salvage pulmonary metastasectomy after immune checkpoint inhibitors (ICIs). However, limited data are available on these patients. We describe a case series of three consecutive patients who underwent salvage pulmonary metastasectomy after ICIs for oligometastatic renal cell carcinoma and discussed the important characteristics of these patients. After salvage pulmonary metastasectomy, none of the patients had recurrent pulmonary metastases, although one of them developed a brain metastasis postoperatively. Our case series suggests that salvage pulmonary metastasectomy after ICIs may control pulmonary metastases in carefully selected patients with oligometastatic renal cell carcinoma, although the management of extrapulmonary metastases may be required after salvage pulmonary metastasectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellImmune Checkpoint InhibitorsKidney NeoplasmsLung NeoplasmsMetastasectomyPneumonectomySalvage TherapyFemaleHumansMaleMiddle AgedTreatment Outcome

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kyoto University, Kyoto, Japan.

ORCID-Profile: Ichiro Sakanoue, Masatsugu Hamaji

Zitieren

APA

Sakanoue, I., Hamaji, M., Nakajima, D., & Date, H. (2025). Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma. The Thoracic and Cardiovascular Surgeon, 73(01), 086-089. https://doi.org/10.1055/a-2411-7055

Vancouver

Sakanoue I, Hamaji M, Nakajima D, Date H. Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma. The Thoracic and Cardiovascular Surgeon. 2025;73(01):086-089. doi:10.1055/a-2411-7055

BibTeX
@article{Sakanoue2025,
  author = {Sakanoue, Ichiro and Hamaji, Masatsugu and Nakajima, Daisuke and Date, Hiroshi},
  title = {Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2025},
  volume = {73},
  number = {01},
  pages = {086--089},
  doi = {10.1055/a-2411-7055}
}
Kostenlos starten →